Last reviewed · How we verify
A Single-Dose, Phase I, Dosimetry, Biodistribution, and Safety Trial of BMS 747158 in Healthy Subjects
The purpose of this clinical research study is to learn the safety and biodistribution of BMS747158 in normal, healthy volunteers.
Details
| Lead sponsor | Lantheus Medical Imaging |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 13 |
| Start date | 2007-09 |
| Completion | 2008-06 |
Conditions
- Healthy
Interventions
- BMS747158
Primary outcomes
- Dosimetry analysis following whole body imaging after resting injection — Imaging takes place 0 - 310 minutes post injection
Countries
United States